Cargando…
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation
Mitochondrial dysfunction and oxidative stress-mediated inflammasome activation play critical roles in the pathogenesis of the non-alcoholic fatty liver disease (NAFLD). Non-steroidal anti-inflammatory drug (NSAID)-activated gene-1 (NAG-1), or growth differentiation factor-15 (GDF15), is associated...
Autores principales: | Wang, Ying, Chen, Chaojie, Chen, Jiajun, Sang, Tingting, Peng, He, Lin, Xiaojian, Zhao, Qian, Chen, Shengjia, Eling, Thomas, Wang, Xingya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079118/ https://www.ncbi.nlm.nih.gov/pubmed/35504134 http://dx.doi.org/10.1016/j.redox.2022.102322 |
Ejemplares similares
-
NAG-1/GDF15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
por: Chrysovergis, Kali, et al.
Publicado: (2014) -
The Effects of Flexibility on dsDNA–dsDNA Interactions
por: Chen, Chuanying, et al.
Publicado: (2022) -
Lower NLRP3 Inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity
por: Wang, Xingya, et al.
Publicado: (2013) -
AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC
por: Hornung, Veit, et al.
Publicado: (2009) -
Released dsDNA‐triggered inflammasomes serve as intestinal radioprotective targets
por: Chen, Long, et al.
Publicado: (2023)